We connect your audience with medical professionals in Mexico
OnlineDoc is the connection layer that links platforms, medical offices, apps, and influencers with medical professionals in Mexico who perform the medical reviews — overseen by a licensed Mexican physician — via video, voice, or data review. We do not offer medical information, diagnosis, or treatment: we connect, and the healthcare professionals decide.
Connection · Mexico
Connection infrastructure
Video · Voice · Data
Infrastructure, not a clinic
OnlineDoc is not a medical provider. We are the infrastructure that connects demand from platforms, apps, influencers, and medical offices with the medical reviews performed by professionals in Mexico — overseen by a licensed Mexican physician — within the regulatory framework.
We don't provide medical services
We do not offer medical information, diagnosis, or treatment. The medical act always belongs to a licensed healthcare professional.
We don't market medications
We do not sell or advertise medications, therapies, or procedures. We list the service types and options available.
We only connect
We facilitate connection via video, voice, or data review between platforms, apps, influencers, medical offices, and our network of medical professionals.
Opening the Mexican market
We provide the medical review, performed by medical professionals in Mexico, to platforms, apps, influencers, and medical offices.
Platforms, apps & influencers
Have an audience and demand? We give you access to medical review by professionals in Mexico, with local compliance.
Medical offices in Mexico
Offer your patients more services — longevity, hormonal optimization, and more — with ready-to-operate connection infrastructure.
Compounding pharmacies & labs
Connect your formulation and testing capacity with a network of reviewers and platforms that need compliance and volume.
Why now, why Mexico
A massive, proven US market
US telehealth ≈ $50B+ (2025), heading to ~$84B by 2030. The lanes we connect are among the fastest-growing: GLP-1 ≈ $53B, female hormone therapy / menopause ≈ $6B, male hormone therapy / testosterone ≈ $2B, longevity ≈ $32B globally.
Mexico is wide open
Mexico's telehealth market ≈ $1.4B (2024) → ~$5.2B by 2030 (25% CAGR) — the fastest-growing in North America — yet no telehealth platform in Mexico is focused on these lanes and longevity.
A built-in expat audience
~800K–1.6M Americans live in Mexico — the world's largest US expat population — many of them retirees seeking affordable, quality care.
A huge domestic market
~130M Mexicans, with some of the world's highest obesity and type-2 diabetes rates — structural demand for these lanes.
Video, voice, or data review
The connection adapts to each lane — from a live consultation to the asynchronous review of clinical data by a medical reviewer.
Video
Live video consultation between the patient and the medical reviewer, with the quality and privacy the medical act demands.
Voice
Voice connection for follow-ups and reviews where video isn't necessary.
Data review
The medical reviewer analyzes lane-specific data (GLP-1s, TRT (male hormone replacement therapy), HRT (female hormone replacement therapy), longevity) and prescribes protocols where appropriate.
One questionnaire, reviewed by physicians
No complicated scheduling. The patient completes a questionnaire; a licensed medical reviewer evaluates it and, where appropriate, prescribes the protocol.
-
1. Connection
The platform or medical office integrates and submits the patient questionnaire.
-
2. Medical review
A licensed reviewer evaluates the data via video, voice, or asynchronously.
-
3. Protocol
Where appropriate, the reviewer prescribes the protocol within the regulatory framework.
-
4. Fulfillment
Partner compounding pharmacies and labs complete delivery.
The lanes we connect
GLP-1s, TRT (male hormone replacement therapy), HRT (female hormone replacement therapy), and longevity through the medical reviewer network. Peptides available as information.
GLP-1's & Weight Loss
Connection for weight-data review
We connect patients with medical reviewers who evaluate data for weight-management protocols using GLP-1 receptor agonists such as semaglutide, tirzepatide, and others. Eligibility, titration, and prescription are the reviewer's decision.
- Connection via video, voice, or data review
- Evaluation by a licensed reviewer
- Prescription when the reviewer determines
- Compliance and coordination with partner pharmacies
TRT — Male hormone replacement therapy
Connection for hormonal-data review
Connection with medical reviewers for testosterone replacement protocols. The reviewer evaluates labs and clinical data and decides independently.
- Lab review by a licensed physician
- Follow-up via video, voice, or data
- Prescription at the reviewer's discretion
- Coordination with partner labs and pharmacies
HRT — Female hormone replacement therapy
Connection for hormonal-data review
Connection with medical reviewers for female hormone replacement protocols. The medical act, including diagnosis and prescription, belongs to the reviewer.
- Hormonal panel review by a licensed physician
- Connection via video, voice, or data review
- Prescription at the reviewer's discretion
- Coordination with partner labs and pharmacies
Longevity Protocols
Connection for longevity-data review
Connection with medical reviewers specialized in longevity and anti-aging medicine. The reviewer interprets the data and defines the protocol autonomously.
- Biomarker review by a licensed physician
- Connection via video, voice, or data
- Protocol defined by the reviewer
- Coordination with partner labs and pharmacies
Medical professionals, overseen by a Mexican physician
Our network is made up of medical professionals specialized in the lanes we connect, overseen by a licensed Mexican physician (Responsable Sanitario). The medical act is always theirs.
Meet the network- Medical reviews by qualified medical professionals
- Overseen by a licensed Mexican physician (cédula profesional)
- Experience in longevity, TRT (male hormone replacement therapy), HRT (female hormone replacement therapy), and GLP-1s
- Clinical independence and Mexican regulatory compliance
Ready to connect?
If you're a platform, an app, an influencer, a medical office, a pharmacy, or a lab, reach out and let's design the connection.